Cost of poor blood pressure control in the UK: 62 000 unnecessary deaths per year

被引:73
作者
He, FJ [1 ]
MacGregor, GA [1 ]
机构
[1] St George Hosp, Sch Med, Blood Pressure Unit, London SW17 0RE, England
关键词
blood pressure control; stroke; ischaemic heart disease;
D O I
10.1038/sj.jhh.1001581
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
High blood pressure is the most important risk factor for cardiovascular disease. With the information on systolic blood pressure from the recently published meta-analysis of prospective studies, we calculated the reductions in stroke and ischaemic heart disease with control of all hypertensives to a systolic blood pressure of 140 mmHg. For adults there would be a reduction of 28-44% in stroke and 20-35% in ischaemic heart disease depending on age. In the UK, this would prevent approximately 21 400 stroke deaths and 41 400 ischaemic heart disease deaths each year. Around half of those who suffer a stroke or ischaemic heart disease survive, there would be a proportionate decrease in these people as well. These amount to approximately 42 800 strokes and 82 800 ischaemic heart diseases saved, making a total of 125 600 events saved a year in the UK. This would result in a reduction in disability and major cost savings both to individuals, their families and the Health Service. The blood pressure levels and control of blood pressure in many countries are similar to those in the UK, so the reductions in stroke and ischaemic heart disease worldwide, if the same control of high blood pressure could be obtained, would be immense.
引用
收藏
页码:455 / 457
页数:3
相关论文
共 11 条
  • [1] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
  • [2] [Anonymous], 1991, JAMA, V265, P3255
  • [3] *BRIT HEART FDN ST, 2002, COR HEART DIS STAT
  • [4] Better blood pressure control: how to combine drugs
    Brown, MJ
    Cruickshank, JK
    Dominiczak, AF
    MacGregor, GA
    Poulter, NR
    Russell, GI
    Thom, S
    Williams, B
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (02) : 81 - 86
  • [5] Selected major risk factors and global and regional burden of disease
    Ezzati, M
    Lopez, AD
    Rodgers, A
    Vander Hoorn, S
    Murray, CJL
    [J]. LANCET, 2002, 360 (9343) : 1347 - 1360
  • [6] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial
    Hansson, L
    Zanchetti, A
    Carruthers, SG
    Dahlöf, B
    Elmfeldt, D
    Julius, S
    Ménard, J
    Rahn, KH
    Wedel, H
    Westerling, S
    [J]. LANCET, 1998, 351 (9118) : 1755 - 1762
  • [7] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
  • [8] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .1. PROLONGED DIFFERENCES IN BLOOD-PRESSURE - PROSPECTIVE OBSERVATIONAL STUDIES CORRECTED FOR THE REGRESSION DILUTION BIAS
    MACMAHON, S
    PETO, R
    CUTLER, J
    COLLINS, R
    SORLIE, P
    NEATON, J
    ABBOTT, R
    GODWIN, J
    DYER, A
    STAMLER, J
    [J]. LANCET, 1990, 335 (8692) : 765 - 774
  • [9] Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
    Murray, CJL
    Lauer, JA
    Hutubessy, RCW
    Niessen, L
    Tomijima, N
    Rodgers, A
    Lawes, CMM
    Evans, DB
    [J]. LANCET, 2003, 361 (9359) : 717 - 725
  • [10] Improved hypertension management and control - results from the Health Survey for England 1998
    Primatesta, P
    Brookes, M
    Poulter, NR
    [J]. HYPERTENSION, 2001, 38 (04) : 827 - 832